Assessment of Safety in Newborns of Mothers Participating in Clinical Trials of Vaccines Administered During Pregnancy
Author(s) -
Flor M. Muñoz,
Leonard E. Weisman,
Jennifer S. Read,
George K. Siberry,
Karen Kotloff,
Jennifer F. Friedman,
Rosemary D. Higgins,
Heather Hill,
Harry Seifert,
Mirjaesin
Publication year - 2014
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciu727
Subject(s) - medicine , clinical trial , pregnancy , immunization , family medicine , vaccine safety , adverse effect , intensive care medicine , pediatrics , immunology , pharmacology , pathology , genetics , antigen , biology
A panel of experts convened by the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, developed proposed guidelines for the evaluation of adverse events in newborns of women participating in clinical trials of maternal immunization in the United States.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom